$SCHL

SCHOLASTIC CORP (SCHL): Results of Operations and Financial Condition

SCHOLASTIC CORP (SCHL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 fy26q4pressrelease.htm EX-99.1 Document Scholastic Reports Fourth Quarter and Fiscal 2026 Results Fiscal 2026 Operating Income of $15.2 Million; Adjusted EBITDA of $151.5 Million, Up 4%, in Line With Guidance Returned Over $285 Million to Shareholders During Fiscal Year

Original reporting
Published Jul 23, 2026, 8:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 23, 2026, 8:04 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$SCHL
Neutral
medium confidence
Mentioned
$SCHL
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SCHLNeutralMed
01

Why it matters

Traders can update models using the provided fiscal 2027 revenue growth (2% to 4%), Adjusted EBITDA ($135M to $145M), and free cash flow ($35M to $40M), while also adjusting for comparable-basis effects from sale-leasebacks and one-time charges.

02

Market read

This is a guidance-bearing earnings release with quantified profitability and cash flow targets, which can drive valuation and positioning for the next quarter(s).

03

What to watch

Education segment funding volatility is cited as a pressure; if that worsens, the fiscal 2027 Adjusted EBITDA range could prove conservative despite the company’s cost-management narrative.

Relevance 7/10Novelty 7/10Timing: after-hours today, ahead of the next trading session’s reaction to fiscal 2027 guidance

Background

The 8-K (Item 2.02) includes Scholastic’s fiscal 2026 fourth-quarter and full-year results and a fiscal 2027 outlook, framed around its multi-year transformation and the full-year impact of prior sale-leaseback transactions.

Company-level read

Ticker impact

$SCHLNeutralMedium confidence
Context

Scholastic reports fiscal 2026 results and issues fiscal 2027 guidance, including revenue growth of 2% to 4% and Adjusted EBITDA of $135M to $145M.

Expected impact

Near-term repricing is possible as traders weigh the guidance range against expectations, with upside/downside skew depending on how the market interprets Education funding volatility and sale-leaseback comparability.

Evidence & confidence

The filing includes multiple quantified results (revenue, operating income, Adjusted EBITDA, free cash flow outlook) and explicit 2027 targets, but the excerpt does not include consensus or prior guidance changes, limiting precision on whether the print is a beat or miss versus Street expectations.

Market effects

Children’s publishing and education content names may see read-across on how sale-leaseback accounting and Education funding volatility affect profitability.

Primarily US-listed small/mid-cap consumer/media sentiment, with limited direct regional spillover.

International segment commentary and modest growth outlook can influence broader sentiment toward global children’s media demand, but impact is likely contained.

Counterpoint

The revenue decline in fiscal 2026 (-3%) and Q4 revenue weakness (-6%) could dominate investor focus, making the EBITDA improvement partly accounting-driven (lease expense and rental income loss) rather than durable operating momentum.

Key entities

  • Scholastic Corporation

    Global children’s publishing, education and media company reporting fiscal 2026 results and issuing fiscal 2027 guidance.

  • Peter Warwick

    CEO and President quoted on transformation progress and the fiscal 2027 outlook.

Related articles

$SCHLMed

Scholastic Corporation Q4 2026 Earnings Call Summary

Scholastic (Scholastic Corporation) reported a 32% rise in adjusted operating income attributed to a multiyear efficiency and integrated publishing and school growth transformation. Management said Book Fairs growth was driven by higher fair counts and digital tools. Fiscal 2027 guidance calls for 2% to 4% revenue growth and higher adjusted EBITDA, with capital returns supported by sale-leasebacks and leverage targets of 2x to 2.5x.

$DRIMedAI 8/10

DRI Healthcare Reports Second Quarter 2026 Results and New Board Appointment

DRI Healthcare Trust (TSX: DHT.UN, DHT.U) reported Q2 2026 results for the quarter ended June 30, 2026: total income $50.1M, total cash receipts $46.5M, and adjusted EBITDA $42.6M. It repurchased 89,513 units at $11.65 and paid a $0.11/unit distribution. After quarter-end, it exercised a put option on Ekterly for about $178M and received FDA approval for Lumvoa (veligrotug), triggering $75M milestone payments.

$LGNDMed

Ligand Pharmaceuticals Incorporated Q2 2026 Earnings Call Summary

Ligand Pharmaceuticals reported Q2 2026 results and discussed its XOMA Royalty acquisition, adding 120+ assets and extending cash flow duration through 2040. Management cited 32% YoY royalty revenue growth and expects 2026 royalty revenue of $225M-$250M with cash opex halved since 2022. Ligand issued a $700M zero-coupon convertible, raised 2026 adjusted EPS guidance to $9.00-$9.50, and expects accretion from XOMA in 2H26 and 2027.

$KDPMed

Keurig Dr Pepper Inc. Q2 2026 Earnings Call Summary

Keurig Dr Pepper reported Q2 2026 results that exceeded expectations, citing double-digit U.S. Refreshment Beverages growth and day-one integration of JDE Peet's. Dr Pepper Zero Sugar grew 30% in retail sales and energy reached 9% market share. U.S. Coffee faced margin pressure from hedging and tariffs. KDP reaffirmed low double-digit EPS growth for 2026 and low-double-digit legacy growth at the high end of 4% to 6%.